Hui Zeng

16PUBLICATIONS
33CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Feb 11, 2026
Corilagin induces pyroptosis in AML cells by activating the TXNIP-caspase-3-GSDME pathway.

Ganlu Feng, Yizhen Li, Ying Wang

|Dec 22, 2025
The effects of daratumumab on bone disease in patients with newly diagnosed multiple myeloma: a multi-center retrospective study.

Xinrong Li, Hua Wang, Yizhen Li

|Oct 07, 2025
Large-scale generation of iNK and CAR-iNK cells from CD34+ haematopoietic stem and progenitor cells for adoptive immunotherapy.

Fangxiao Hu, Jianhuan Li, Yao Wang

|Feb 05, 2025
Targeting ceramide transfer protein sensitizes AML to FLT3 inhibitors via a GRP78-ATF6-CHOP axis.

Xiaofan Sun, Yue Li, Juan Du

|Dec 18, 2024
Hexamethylene amiloride induces lysosome-mediated cell death in multiple myeloma through transcription factor E3.

Nianhui Yang, Zexuan Dong, Weihao Xiao

|Aug 07, 2024
Cxcl10 and Cxcr3 regulate self-renewal and differentiation of hematopoietic stem cells.

Fangshu Liu, Xiaofan Sun, Suqi Deng

Pageof 3

Frequent Collaborators

5 joint publications

Juan Du

2 joint publications

Yunqing Lin

2 joint publications

Qitong Weng

2 joint publications

Jiacheng Xu